South Jordan, UT, United States of America

Ferdinand Kiemeneij

This inventor holds 1 USPTO granted patent. Top assignee: Merit Medical Systems, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ferdinand Kiemeneij. Retrieved from https://idiyas.com/inventor/ferdinand-kiemeneij-0cu36u8g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ferdinand Kiemeneij: Inventor of a Hemostasis Device

Introduction

Ferdinand Kiemeneij is an inventor associated with South Jordan, Utah, and Merit Medical Systems, Inc. His patent work addresses devices and methods for controlling bleeding at vascular puncture sites.

Latest Patents

The provided information lists 1 patent for Kiemeneij: “Hemostasis Devices and Methods of Use.” The invention describes a device that applies compressive force to a puncture site in a patient’s vessel, including arteries in the hand, wrist, or foot. Multiple bands can help position and hold a compression member over the site, and an inflation port can connect to an inflatable bladder.

Career Highlights

Kiemeneij’s listed invention focuses on supporting hemostasis after a vascular procedure. Its design combines positioning and compression features intended to maintain pressure at the puncture site.

Collaborations

Kiemeneij is associated with Merit Medical Systems, Inc. His listed coworker is Tyler Rees.

Conclusion

Ferdinand Kiemeneij’s patent describes a practical approach to applying and maintaining compression at vascular puncture sites, reflecting his work in medical-device innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…